Rhinovirus Suppresses TGF-β-GARP Presentation by Peripheral NK Cells

Cells. 2022 Dec 28;12(1):129. doi: 10.3390/cells12010129.

Abstract

Asthma is a chronic airway disease whose exacerbations are often triggered by rhinovirus infection. TGF-β1 induces rhinovirus replication in infected cells. Moreover, TGF-β1 is a pleiotropic mediator that is produced by many immune cells in the latent, inactive form bound to the latency-associated peptide (LAP) and to the transmembrane protein glycoprotein A repetitions predominant (GARP). In this study we wanted to investigate the effect of rhinovirus infection on the TGF-β secretion and the downstream signaling via TGF-βRI/RII in peripheral blood mononuclear cells from control and asthmatic patients after rhinovirus infection ex vivo. Here, we found a significant upregulation of TGF-βRII in untouched PBMCs of asthmatics as well as a suppression of TGF-β release in the rhinovirus-infected PBMC condition. Moreover, consistent with an effect of TGF-β on Tregs, PBMCs infected with RV induced Tregs, and TGF-βRII directly correlated with RV1b mRNA. Finally, we found via flow cytometry that NK cells expressed less GARP surface-bound TGF-β, while cytokine-producing NKbright cells were induced. In summary, we show that rhinovirus infection inhibits TGF-β release in PBMCs, which results in the activation of both Treg and NK cells.

Keywords: NK cells; TGF-β; TGF-β RI; TGF-β RII; asthma; rhinovirus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asthma*
  • Enterovirus Infections*
  • Glycoproteins
  • Humans
  • Killer Cells, Natural / metabolism
  • Leukocytes, Mononuclear / metabolism
  • Membrane Proteins / metabolism
  • Rhinovirus
  • Transforming Growth Factor beta / metabolism
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • Membrane Proteins
  • Glycoproteins

Grants and funding

S.K. was supported by the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg (Project A82). This work was supported by a grant from the Collaborative Research Centre (CRC) 1181 for the project TP-B08 N (Molecular mechanisms controlling regulatory T cell activation in the resolution of asthma), at the University hospital in Erlangen, Germany and the European Grant Horizon SynAir-G (Project: 101057271; https://doi.org/10.3030/101057271, accessed on 22 December 2022) awarded to S.F.